Isthmin-1 (ISM1): A Multifunctional Secreted Protein with Roles in Development, Angiogenesis, and Metabolism

Introduction

Isthmin-1 (ISM1) is a secreted glycoprotein that was first identified in 2002 through an unbiased secretion cloning screen of Xenopus laevis gastrula embryos [pera-2002-isthmin-discovery-abstract]. The protein was named after the isthmus (midbrain-hindbrain boundary) where it was prominently expressed during early embryonic development. Since its discovery, ISM1 has emerged as a multifunctional protein with diverse roles spanning embryonic patterning, angiogenesis inhibition, apoptosis regulation, vascular permeability, immune modulation, and metabolic control [li-2023-isthmin-review-abstract].

Human ISM1 (UniProt: B1AKI9) encodes a precursor protein of 499 amino acids (approximately 60 kDa), while the mouse ortholog contains 461 amino acids. The protein exhibits remarkable evolutionary conservation, with mouse and human ISM1 sharing 93% amino acid sequence identity, and 78% identity with the frog ortholog [pera-2002-isthmin-discovery-abstract]. This high degree of conservation suggests critical cellular functions maintained across vertebrate evolution [valle-dorado-2022-isthmin-family-abstract].

ISM1 functions primarily as a secreted signaling molecule that acts through multiple cell-surface receptors to regulate diverse biological processes. The protein has garnered significant attention for its potential therapeutic applications in cancer treatment, metabolic disease, and lung pathology, though recent structural studies have challenged some of its reported metabolic functions [cao-2025-crystal-structure-abstract].

Protein Structure and Domains

ISM1 possesses a modular architecture consisting of three main regions: an N-terminal signal peptide, a central thrombospondin type 1 repeat (TSR) domain, and a C-terminal adhesion-associated domain in MUC4 and other proteins (AMOP) domain [li-2023-isthmin-review-abstract][valle-dorado-2022-isthmin-family-abstract].

The TSR domain encompasses approximately 60 amino acids and forms a reverse three-stranded beta-sheet structure stabilized by three conserved disulfide bonds. This domain contains conserved tryptophan, arginine, and cysteine residues characteristic of TSR-containing proteins. ISM1 contains a "WSLW motif" that is potentially involved in heparin binding and may contribute to its anti-angiogenic functions [valle-dorado-2022-isthmin-family-abstract]. The TSR domain is implicated broadly in cell-cell and cell-ECM interactions, tumor metastasis, angiogenesis, TGF-beta activation, wound healing, and axon guidance.

The AMOP domain comprises approximately 100-160 amino acids and represents a novel extracellular domain originally identified in certain splice variants of MUC4. This domain has been described in only four proteins: MUC4, SUSD2, ISM1, and ISM2 [li-2023-isthmin-review-abstract]. The recent crystal structure determination of ISM1's AMOP domain (PDB: 9C6T) revealed a distinctive fold with similarities to bacterial streptavidin. The structure has been described as resembling "a hand holding chopsticks," where the central antiparallel beta-strands function as fingers, terminal helices act as chopsticks, and middle helices serve as a thumb [cao-2025-crystal-structure-abstract]. This streptavidin-like barrel architecture is conserved among AMOP domains, though surface helices and loops vary considerably, providing structural plasticity that may underpin diverse functions.

Importantly, the AMOP domain contains conserved cysteine residues involved in disulfide bond formation (eight invariant cysteines) and harbors a critical RKD sequence that was initially proposed as an integrin-binding motif [zhang-2011-integrin-dual-effect-abstract]. However, recent structural analysis has challenged this interpretation, demonstrating significant steric clashes between the AMOP domain and integrin receptors that are incompatible with canonical RGD-mediated integrin binding [cao-2025-crystal-structure-abstract]. The AMOP domain also possesses a KGD motif reported to bind integrin alphaIIbeta3.

ISM1 undergoes critical post-translational modifications including N-glycosylation and C-mannosylation that regulate its secretion and function [osorio-2019-nodal-signaling-abstract][cao-2025-crystal-structure-abstract]. Detailed biochemical analysis has revealed two putative N-glycosylation sites at positions Asn39 and Asn285, and two C-mannosylation sites at Trp223 and Trp226 within the TSR domain [yoshimoto-2021-cmannosylation-abstract].

A landmark study by Yoshimoto et al. demonstrated that C-mannosylation of ISM1 regulates intracellular transport from the endoplasmic reticulum to the Golgi apparatus and is essential for efficient secretion [yoshimoto-2021-cmannosylation-abstract]. When C-mannosylation-defective ISM1 mutants were expressed, secretion decreased significantly compared to wild-type cells. Interestingly, when C-mannosylation is lacking, N-glycosylation at Asn39 and Asn285 is induced as a compensatory mechanism to rescue secretory function. This interplay between C-mannosylation and N-glycosylation represents a novel regulatory mechanism for ISM1 secretion. Because the TSR domain is highly conserved across species, C-mannosylation of ISM1 is likely present in other vertebrates [valle-dorado-2022-isthmin-family-abstract].

Receptor Binding and Signal Transduction

ISM1 exerts its biological effects through at least three identified receptors, each mediating distinct cellular responses depending on cell type and physiological context.

GRP78: The High-Affinity Receptor

Cell-surface glucose-regulated protein 78 kDa (GRP78) serves as a high-affinity receptor for ISM1, with a dissociation constant (Kd) of 8.6 nM [chen-2014-grp78-apoptosis-abstract]. GRP78, also known as BiP (binding immunoglobulin protein), is a member of the HSP70 heat shock chaperone family and serves as a major endoplasmic reticulum stress response protein. Under normal conditions, GRP78 predominantly localizes to the ER lumen. However, in stressed cells, including cancer cells and activated endothelial cells, GRP78 is overexpressed and a portion translocates to the cell surface where it serves as a signaling receptor [chen-2014-grp78-apoptosis-abstract].

The ISM1-GRP78 interaction triggers two distinct downstream effects. First, in terms of apoptosis induction, ISM1 binding to cell-surface GRP78 leads to clathrin-dependent internalization, followed by trafficking to mitochondria where ISM1 interacts with adenine nucleotide translocase (AAC/ANT), blocking ADP/ATP exchange and inducing mitochondrial dysfunction and apoptosis [chen-2014-grp78-apoptosis-abstract]. This selective targeting mechanism makes ISM1 an attractive agent for cancer therapy, as cancer cells typically express high levels of cell-surface GRP78 while normal cells remain resistant to ISM1-induced apoptosis.

Second, regarding vascular permeability regulation, ISM1 binding to GRP78 induces a direct GRP78-Src interaction, leading to cytoplasmic Src activation and enhanced endothelial monolayer permeability [venugopal-2015-vascular-permeability-abstract]. Systemic ISM1 administration leads to profound lung vascular hyperpermeability, and ISM1 is significantly upregulated in LPS-treated mouse lung, contributing to pulmonary vascular dysfunction in acute lung injury [venugopal-2015-vascular-permeability-abstract].

Integrin alphavbeta5: The Low-Affinity Receptor

Integrin alphavbeta5 serves as a low-affinity receptor for ISM1 [zhang-2011-integrin-dual-effect-abstract]. Remarkably, ISM1 exhibits dual functionality through this receptor depending on its physical state. Soluble ISM1 functions as an integrin alphavbeta5 antagonist, suppressing endothelial cell tube formation and inducing apoptosis through integrin-mediated death (IMD). This involves direct recruitment and activation of caspase-8 without causing anoikis [zhang-2011-integrin-dual-effect-abstract]. Activated caspase-8 can first be detected 4 hours after ISM treatment, and knockdown of the beta5-integrin subunit suppresses caspase-8 and caspase-3 activation as well as PARP cleavage.

In contrast, immobilized ISM1 promotes endothelial cell adhesion, survival, and haptotactic migration by functioning as an integrin alphavbeta5 agonist and activating focal adhesion kinase (FAK) [zhang-2011-integrin-dual-effect-abstract]. This dual functionality has significant implications for understanding how ISM1 may perform therapeutically in vivo, where its physical state fundamentally alters biological outcomes through the same receptor.

Integrin alpha8beta1: Developmental Receptor

More recently, integrin alpha8beta1 was identified as a receptor for ISM1 specifically in the context of kidney development [gao-2023-kidney-development-abstract]. Using HRP-induced proximity-labeling in embryonic kidney rudiments (E11.5), researchers demonstrated that ISM1 binding to integrin alpha8beta1 activates downstream targets including FAK, AKT, and ERK, promoting cell-cell adhesion and mesenchyme condensation during early renal branching morphogenesis.

NODAL Signaling Pathway Interaction

Beyond direct receptor binding, ISM1 also modulates the NODAL signaling pathway through direct interaction with pathway components. ISM1 binds to both the NODAL ligand and the type I receptor ACVR1B through its AMOP domain, compromising NODAL-ACVR1B complex formation and down-regulating SMAD2 phosphorylation [osorio-2019-nodal-signaling-abstract]. Notably, ISM1 specifically inhibits NODAL-induced signaling while having minimal effect on TGF-beta1, ACTIVIN-A, or BMP4 signaling, demonstrating ligand-dependent selectivity within the TGF-beta superfamily.

Biological Functions

Anti-angiogenic Activity and Cancer

ISM1 potently inhibits angiogenesis through multiple mechanisms. Both full-length ISM1 and the AMOP domain fragment inhibit capillary network formation in a dose-dependent manner [li-2023-isthmin-review-abstract]. The protein suppresses tumor growth and angiogenesis in mouse models when stably overexpressed in cancer cells, including melanoma and glioma models.

The anti-tumor properties of ISM1 extend beyond anti-angiogenesis to include direct apoptosis induction in cancer cells expressing high levels of cell-surface GRP78. Normal cells and benign tumor cells, which express low levels of cell-surface GRP78, remain resistant to ISM1-induced apoptosis [chen-2014-grp78-apoptosis-abstract]. A peptide derived from the AMOP domain (BC71) activates p53 and caspase-8 pathways.

Building on these anti-cancer properties, researchers have developed therapeutic peptides derived from ISM1's AMOP domain. The cyclic peptide BC71, harboring the RKD motif from ISM1's AMOP domain, functions as a potent proapoptotic ligand of cell-surface GRP78 [kao-2018-bc71-peptide-abstract]. Using hydrogen-deuterium exchange mass spectrometry, researchers identified that BC71 preferentially binds ATP-bound GRP78 at amino acids 244-257. Critically, intravenous administration of BC71 suppressed xenograft tumor growth in mice as a single agent, with significant reduction in tumor angiogenesis and increased apoptosis via caspase-8 activation. Fluorescent-labeled BC71 accumulates specifically in tumors by targeting cell-surface GRP78, suggesting potential applications not only as a therapeutic but also as a PET imaging agent for cancer prognosis [kao-2018-bc71-peptide-abstract].

Paradoxically, ISM1 expression is elevated in certain cancers including colorectal cancer, where it correlates with shorter overall survival, lymph node involvement, and advanced disease stages [wu-2021-colorectal-cancer-abstract]. In colorectal cancer, ISM1 promotes epithelial-mesenchymal transition (EMT) markers (increased N-cadherin and Snail, decreased E-cadherin) and correlates positively with immune checkpoint markers including PD-L1, PD-1, CTLA-4, and LAG3, potentially contributing to immunotherapy resistance. ISM1 expression is also elevated in gastric cancer and hepatocellular carcinoma. This apparent contradiction between ISM1's anti-angiogenic properties and its elevation in cancer remains incompletely understood and may reflect context-dependent functions in the tumor microenvironment [li-2023-isthmin-review-abstract].

Developmental Functions

ISM1 plays essential roles during embryonic development. Its expression at the midbrain-hindbrain boundary as part of the FGF-8 synexpression group initially suggested developmental patterning functions [pera-2002-isthmin-discovery-abstract].

In terms of left-right asymmetry and organ positioning, ectopic ISM1 expression causes defective left-right asymmetry and abnormal heart positioning in chick embryos through inhibition of NODAL signaling [osorio-2019-nodal-signaling-abstract]. Treatment with ISM1 reduced asymmetric NODAL gene expression in the left lateral plate mesoderm by approximately 70%.

For kidney development, ISM1 is expressed in metanephric mesenchyme and regulates mesenchyme condensation through integrin alpha8beta1-mediated cell adhesion. ISM1-deficient mice exhibit defective ureteric bud bifurcation and impaired mesenchyme condensation, ultimately leading to renal agenesis and hypoplasia/dysplasia in approximately 60% of homozygous mutants [gao-2023-kidney-development-abstract]. ISM1 regulates this process through enhancement of GDNF/Ret signaling, which is essential for normal branching morphogenesis.

Regarding craniofacial development, ISM1 heterozygous deletions are associated with cleft lip and palate susceptibility in humans. Knockdown of ISM1 in Xenopus results in severe perturbation of craniofacial morphogenesis and reduces expression of LHX8, a known clefting locus [li-2023-isthmin-review-abstract].

ISM1 also functions in hematopoiesis, as demonstrated through detailed studies in zebrafish. Berrun et al. identified ism1 as highly expressed in hematopoietic-supportive stromal cell lines and showed that it is co-expressed with FGF ligands essential for HSC specification [berrun-2018-hematopoiesis-abstract]. Loss-of-function experiments using morpholinos revealed that ism1 knockdown leads to reduced numbers of neutrophils, macrophages, and erythrocytes. Clonal methylcellulose assays demonstrated a reduction in total hematopoietic stem and progenitor cells (HSPCs). Morphant embryos displayed slowed circulation and blood pooling at 48 hours post-fertilization, while hearts appeared morphologically normal, indicating a specific hematopoietic defect rather than cardiovascular dysfunction [berrun-2018-hematopoiesis-abstract]. These findings establish ISM1 as required for normal generation of HSPCs and their downstream progeny during vertebrate hematopoiesis.

Metabolic Functions and Controversy

A landmark 2021 study identified ISM1 as an adipokine that promotes glucose uptake in adipose tissue while simultaneously suppressing lipid synthesis in the liver [jiang-2021-adipokine-glucose-abstract]. ISM1 was reported to activate PI3K-AKT signaling independently of insulin and IGF-1 receptors, and ISM1 knockout mice exhibited impaired glucose tolerance, reduced adipose glucose uptake, and reduced insulin sensitivity. Therapeutic dosing of recombinant ISM1 improved diabetes in diet-induced obese mice and ameliorated hepatic steatosis [jiang-2021-adipokine-glucose-abstract].

However, a recent structural and biochemical study has challenged these findings [cao-2025-crystal-structure-abstract]. Researchers at Yale demonstrated that purified ISM1 alone does NOT activate AKT phosphorylation in pre-adipocytes. Instead, co-purifying contaminants from expression systems, specifically PDGF-A and GDF15, were responsible for the metabolic activity previously attributed to ISM1. Both proteins copurify through immobilized metal affinity chromatography (IMAC) purification, and recombinant PDGF-AA robustly stimulated AKT phosphorylation at nanomolar concentrations. GDF15 has established roles in metabolism including increased insulin sensitivity and decreased liver lipogenesis, matching ISM1's reported metabolic effects [cao-2025-crystal-structure-abstract].

This controversy remains unresolved and calls for careful reassessment of ISM1's reported metabolic functions using highly purified protein preparations verified for the absence of contaminating growth factors.

Adding further complexity, a recent clinical study found that serum ISM1 levels are positively correlated with macrovascular complications in type 2 diabetic patients [wang-2025-macrovascular-abstract]. Wang et al. demonstrated that ISM1 levels were significantly higher in T2DM subjects than normal controls, and highest in patients with macrovascular complications (median 2.07 ng/mL vs 1.20 ng/mL in T2DM). Positive correlations emerged between ISM1 and systolic/diastolic blood pressure, triglycerides, fasting blood glucose, HbA1c, and insulin resistance markers. This contrasts with earlier observations suggesting that elevated ISM1 may be protective against diabetes, and suggests context-dependent changes in ISM1 expression during disease progression that warrant further investigation.

Lung Homeostasis and Inflammatory Regulation

ISM1 is highly expressed in the mouse and human lung and plays important roles in pulmonary homeostasis. ISM1-deficient mice exhibit spontaneous and progressive lung emphysema, increased alveolar macrophage number and functional heterogeneity, enduring lung inflammation, and significant lung function decline, phenotypes similar to human COPD [nguyen-2022-lung-injury-abstract]. ISM1 functions as a lung-resident anti-inflammatory protein that selectively triggers apoptosis of alveolar macrophages harboring high levels of cell-surface GRP78.

In acute lung injury models, ISM1 deficiency leads to heightened acute inflammatory response with enhanced neutrophil and monocyte infiltration, increased pro-inflammatory cytokines including TNF-alpha, and greater post-injury fibrosis [nguyen-2022-lung-injury-abstract]. ISM1 suppresses inflammation through NF-kappaB pathway inhibition. Therapeutically, intranasal delivery of recombinant ISM1 reduces LPS-induced leukocyte infiltration and dampens inflammatory cascades, suggesting potential clinical applications for ARDS and pulmonary fibrosis.

The Isthmin Protein Family: ISM1 and ISM2

ISM1 belongs to a small protein family that includes ISM2 (also known as Tail), both containing the characteristic TSR-AMOP domain architecture [valle-dorado-2022-isthmin-family-abstract]. Human ISM1 (~60 kDa) and ISM2 (~63.9 kDa) share similar structures but exhibit distinct expression patterns and potentially different functions.

ISM1 is located on human chromosome 20 (20p12.1), comprising 464 amino acids encoded by six exons spanning 77.7 kb. In zebrafish, while the teleost genome was duplicated early in evolution, there is only one ism1 copy that shares synteny with human ISM1, whereas two ism2 paralogs exist (ism2a and ism2b) on different chromosomes [berrun-2018-hematopoiesis-abstract][valle-dorado-2022-isthmin-family-abstract].

Phylogenetic analysis demonstrates remarkable conservation of both ISM1 and ISM2 across vertebrates, suggesting important cellular functions [valle-dorado-2022-isthmin-family-abstract]. ISM1 contains a "WSLW motif" while ISM2 has "WSPW," both potentially involved in heparin binding. Both proteins possess an RKD motif in the AMOP domain implicated in integrin binding, though structural studies have challenged whether this motif can actually engage integrins.

The functional relationship between ISM1 and ISM2 remains incompletely characterized. In developmental timing, ism1 expression in zebrafish is detected early during shield stage, tail-bud stage, and early somitogenesis, while ism2 expression is not detected until 24 hours post-fertilization [valle-dorado-2022-isthmin-family-abstract]. In pathological contexts, ISM1 and ISM2 show differential expression: in preeclampsia, trophoblastic cells strongly express ISM1 while serum ISM2 concentrations are reduced; conversely, ISM2 shows prominent expression in choriocarcinoma. Both ISM1 upregulation in multiple cancers (gastric, hepatocellular, colorectal) and ISM2 in choriocarcinoma suggest distinct roles in tumorigenesis [valle-dorado-2022-isthmin-family-abstract].

Tissue Expression and Localization

ISM1 is a secreted protein that acts extracellularly. In terms of tissue distribution, ISM1 is expressed in diverse tissues including brain, lung, vasculature, skin, mucosal surfaces, and selected lymphocyte populations [li-2023-isthmin-review-abstract][valle-dorado-2022-isthmin-family-abstract]. The lung shows particularly high expression, establishing ISM1 as a lung-resident protein with immunomodulatory functions.

A detailed study of ISM1 expression in the immune system revealed selective expression in specific lymphocyte populations [valle-rios-2014-immune-cells-abstract]. ISM1 is expressed by DX5+NKp46+ NK and NKT cells in mouse lung. Notably, ISM1 expression increases significantly when CD4+ T cells are polarized to the Th17 lineage in vitro, with expression levels correlating with RORgammat transcription factor levels, a marker of Th17 commitment. Importantly, IFN-gamma inhibits ISM1 expression during T cell polarization, suggesting cytokine-mediated regulation [valle-rios-2014-immune-cells-abstract]. Given ISM1's anti-angiogenic and immunomodulatory properties, these findings suggest ISM1 may mediate effector functions of Th17, NKT, and NK cells in innate and acquired immune responses.

Regarding developmental expression, during embryogenesis ISM1 shows dynamic spatiotemporal expression patterns. In Xenopus, it is strongly expressed maternally and shows zygotic expression in the ventral blastopore lip, notochord, midbrain-hindbrain boundary, neural crest, ear vesicle, and developing blood islands [pera-2002-isthmin-discovery-abstract]. In developing kidney, ISM1 is initially broadly expressed in both condensed and surrounding metanephric mesenchyme and ureteric epithelium at E10.5-E11.5, becoming specifically expressed in mesenchyme from E12.5 onward [gao-2023-kidney-development-abstract].

The protein acts in an autocrine and paracrine manner. As a secreted protein, ISM1 acts on nearby cells expressing appropriate receptors (GRP78, integrins). Its effects on endothelial cells, cancer cells, alveolar macrophages, and mesenchymal cells demonstrate its paracrine signaling capacity.

Aging and Longevity

Emerging research has identified ISM1 as a potential biomarker of aging and a factor with rejuvenation properties. Li et al. demonstrated that ISM1 expression decreases with age in fish (Nothobranchius guentheri), mice, and humans, with reduced levels observed in liver, muscle, and serum [li-2022-aging-biomarker-abstract]. Strikingly, oral treatment with recombinant ISM1 increased maximum lifespan by 7.2% (from 51.5 to 55.2 weeks) and mean lifespan by 7.5% (from 45.4 to 48.8 weeks) in killifish. Treatment also reduced accumulation of aging markers including liver lipofuscin, reactive oxygen species, and protein oxidation in muscle, suggesting ISM1 may be both an aging biomarker and a potential rejuvenation factor.

Further supporting a role in age-related pathology, cardiac-specific overexpression of ISM1 significantly mitigated insulin resistance and improved cardiac function in aging mice [hu-2024-cardiac-aging-abstract]. ISM1 overexpression alleviated cellular senescence, cardiac inflammation, and dysfunction in both natural and accelerated cardiac aging models. Mechanistically, ISM1 promotes glycolysis and activates SIRT1 (a key longevity-associated deacetylase) through enhancing glucose uptake via GLUT4 translocation [hu-2024-cardiac-aging-abstract]. Since SIRT1 activation extends lifespan in various organisms, these findings position ISM1 as a potential therapeutic target for age-related cardiac disease, though caution is warranted given the evolutionary distance between model organisms and humans.

Role in Disease

Beyond the developmental disorders discussed above (renal agenesis/hypoplasia, cleft lip/palate), ISM1 has been implicated in several disease contexts.

For cancer, elevated ISM1 expression correlates with progression in gastric cancer, hepatocellular carcinoma, and colorectal cancer, where it serves as an independent prognostic indicator [wu-2021-colorectal-cancer-abstract]. ISM1's role in promoting EMT and correlating with immunosuppressive markers suggests involvement in tumor progression and immunotherapy resistance.

Regarding pulmonary diseases, ISM1 deficiency phenocopies aspects of COPD, and ISM1 dysfunction may contribute to acute lung injury and pulmonary fibrosis [nguyen-2022-lung-injury-abstract].

For metabolic disease, if ISM1's metabolic functions are confirmed following resolution of the recent controversy, reduced ISM1 levels or signaling could contribute to type 2 diabetes and NAFLD [jiang-2021-adipokine-glucose-abstract]. Human studies have shown correlations between circulating ISM1 levels and metabolic parameters, though interpretations remain tentative pending clarification of ISM1's direct metabolic activities.

Open Questions

Several significant questions remain unresolved in ISM1 biology:

1. Metabolic function controversy: The discrepancy between the reported metabolic functions of ISM1 and the recent structural study attributing these effects to contaminants requires resolution. Independent replication with rigorously purified ISM1 preparations is essential.

2. Receptor identification in adipocytes: If ISM1 does have metabolic functions, the specific receptor mediating glucose uptake in adipocytes remains unidentified, as neither GRP78 nor known integrins appear responsible.

3. Paradoxical roles in cancer: How does ISM1 function as an anti-angiogenic, pro-apoptotic protein yet become elevated in multiple cancers? Understanding this context-dependency may reveal new therapeutic opportunities.

4. Integrin binding mechanism: The recent structural data suggesting the RKD motif cannot bind integrins contradicts functional studies demonstrating integrin-mediated effects. The molecular basis of ISM1-integrin interaction requires clarification.

5. Relationship between ISM1 and ISM2: While both isthmin family members share the TSR-AMOP architecture, their distinct expression patterns (temporal and tissue-specific) and differential disease associations suggest non-redundant functions that require elucidation.

6. Therapeutic development: Given ISM1's anti-angiogenic and pro-apoptotic properties toward cancer cells and its protective effects in lung, development of ISM1-based therapeutics or ISM1 pathway modulators represents an important translational direction.

7. Post-translational regulation: How do N-glycosylation and C-mannosylation regulate ISM1 function in different tissues? Are there pathophysiological conditions where altered modification status affects ISM1 activity or receptor binding?

8. Contradictory clinical findings: Why do some studies show lower ISM1 in diabetes (suggesting protective effects) while others show elevated ISM1 correlating with macrovascular complications? Understanding the temporal dynamics and tissue-specific regulation of ISM1 during disease progression is critical for therapeutic development.

9. Hematopoietic mechanisms: What is the molecular mechanism by which ISM1 supports HSPC generation? Does ISM1 act directly on HSPCs or through the stromal microenvironment? What receptors mediate ISM1's hematopoietic functions?

References

• [pera-2002-isthmin-discovery-abstract]: Pera EM, Kim JI, Martinez SL, Brechner M, Li SY, Wessely O, De Robertis EM. Isthmin is a novel secreted protein expressed as part of the Fgf-8 synexpression group in the Xenopus midbrain-hindbrain organizer. Mech Dev. 2002;116(1-2):169-72. PMID: 12128218. DOI: 10.1016/s0925-4773(02)00123-5

• [chen-2014-grp78-apoptosis-abstract]: Chen M, Zhang Y, Yu VC, Chong YS, Yoshioka T, Ge R. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction. Cell Death Differ. 2014;21(5):797-810. PMID: 24464222. PMCID: PMC3978310. DOI: 10.1038/cdd.2014.3

• [zhang-2011-integrin-dual-effect-abstract]: Zhang Y, Chen M, Venugopal S, Zhou Y, Xiang W, Li YH, Lin Q, Kini RM, Chong YS, Ge R. Isthmin exerts pro-survival and death-promoting effect on endothelial cells through alphavbeta5 integrin depending on its physical state. Cell Death Dis. 2011;2(5):e153. PMID: 21544092. DOI: 10.1038/cddis.2011.37

• [jiang-2021-adipokine-glucose-abstract]: Jiang Z, Zhao M, Voilquin L, et al. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis. Cell Metab. 2021;33(9):1836-1852.e11. PMID: 34348115. PMCID: PMC8429235. DOI: 10.1016/j.cmet.2021.07.010

• [osorio-2019-nodal-signaling-abstract]: Osório L, Wu X, Wang L, Jiang Z, Neideck C, Sheng G, Zhou Z. ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development. J Cell Biol. 2019;218(7):2388-2402. PMID: 31171630. PMCID: PMC6605798. DOI: 10.1083/jcb.201801081

• [gao-2023-kidney-development-abstract]: Gao G, Li X, Jiang Z, et al. Isthmin-1 (Ism1) modulates renal branching morphogenesis and mesenchyme condensation during early kidney development. Nat Commun. 2023;14:2459. PMID: 37185772. PMCID: PMC10130008. DOI: 10.1038/s41467-023-37992-x

• [venugopal-2015-vascular-permeability-abstract]: Venugopal S, Chen M, Liao W, Er SY, Wong WSF, Ge R. Isthmin is a novel vascular permeability inducer that functions through cell-surface GRP78-mediated Src activation. Cardiovasc Res. 2015;107(1):131-42. PMID: 25952901. DOI: 10.1093/cvr/cvv142

• [nguyen-2022-lung-injury-abstract]: Nguyen N, Xu S, Lam TYW, Liao W, Wong WSF, Ge R. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice. Mol Med. 2022;28:72. PMID: 35745564. PMCID: PMC9233842. DOI: 10.1186/s10020-022-00500-w

• [li-2023-isthmin-review-abstract]: Li J, Zhao X, Xin X, et al. Advances in research of biological functions of Isthmin-1. J Cell Commun Signal. 2023;17:507-521. PMID: 36635535. PMCID: PMC10409700. DOI: 10.1007/s12079-023-00732-3

• [wu-2021-colorectal-cancer-abstract]: Wu Y, Liang X, Ni J, Zhao R, Shao S, Lu S, Han W, Yu L. Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer. Front Cell Dev Biol. 2021;9:681240. DOI: 10.3389/fcell.2021.681240

• [valle-dorado-2022-isthmin-family-abstract]: Valle-Dorado MG, et al. Isthmin—A Multifaceted Protein Family. Int J Mol Sci. 2022;24(1):133. PMCID: PMC9818725. DOI: 10.3390/ijms24010133

• [cao-2025-crystal-structure-abstract]: Cao J, et al. Crystal structure of Isthmin-1 and reassessment of its functional role in pre-adipocyte signaling. Nat Commun. 2025;16:3675. PMID: 40234450. PMCID: PMC12000326. DOI: 10.1038/s41467-025-58828-w

• [yoshimoto-2021-cmannosylation-abstract]: Yoshimoto S, Katayama K, Suzuki T, Dohmae N, Simizu S. Regulation of N-glycosylation and secretion of Isthmin-1 by its C-mannosylation. Biochim Biophys Acta Gen Subj. 2021;1865(3):129840. PMID: 33412225. DOI: 10.1016/j.bbagen.2020.129840

• [berrun-2018-hematopoiesis-abstract]: Berrun A, Harris E, Stachura DL. Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish. PLoS One. 2018;13(5):e0196872. PMID: 29758043. PMCID: PMC5951578. DOI: 10.1371/journal.pone.0196872

• [wang-2025-macrovascular-abstract]: Wang Y, Feng Y, Wang X, et al. Serum Isthmin-1 levels are positively correlated with macrovascular complications in type 2 diabetic patients. Front Endocrinol. 2025;16:1594158. DOI: 10.3389/fendo.2025.1594158

• [li-2022-aging-biomarker-abstract]: Li C, Song L, Zhou Y, Yuan J, Zhang S. Identification of Isthmin1 in the small annual fish, Nothobranchius guentheri, as a novel biomarker of aging and its potential rejuvenation activity. Biogerontology. 2022;23(1):99-114. PMID: 34988750. DOI: 10.1007/s10522-021-09948-5

• [hu-2024-cardiac-aging-abstract]: Hu M, Zhang X, Gao YP, et al. Isthmin-1 Improves Aging-Related Cardiac Dysfunction in Mice through Enhancing Glycolysis and SIRT1 Deacetylase Activity. Aging Dis. 2024;15(6):2682-2696. PMID: 38300636. PMCID: PMC11567257. DOI: 10.14336/AD.2024.0113

• [kao-2018-bc71-peptide-abstract]: Kao C, Chandna R, Ghode A, et al. Proapoptotic Cyclic Peptide BC71 Targets Cell-Surface GRP78 and Functions as an Anticancer Therapeutic in Mice. EBioMedicine. 2018;33:22-32. PMID: 29907328. PMCID: PMC6085501. DOI: 10.1016/j.ebiom.2018.06.004

• [valle-rios-2014-immune-cells-abstract]: Valle-Rios R, Maravillas-Montero JL, Burkhardt AM, et al. Isthmin 1 is a secreted protein expressed in skin, mucosal tissues, and NK, NKT, and Th17 cells. J Interferon Cytokine Res. 2014;34(10):795-801. PMID: 24956034. PMCID: PMC4186767. DOI: 10.1089/jir.2013.0137

Citations

1. berrun-2018-hematopoiesis-abstract.md
2. cao-2025-crystal-structure-abstract.md
3. chen-2014-grp78-apoptosis-abstract.md
4. chen-2014-grp78-apoptosis-summary.md
5. gao-2023-kidney-development-abstract.md
6. hu-2024-cardiac-aging-abstract.md
7. jiang-2021-adipokine-glucose-abstract.md
8. jiang-2021-adipokine-glucose-summary.md
9. kao-2018-bc71-peptide-abstract.md
10. li-2022-aging-biomarker-abstract.md
11. li-2023-isthmin-review-abstract.md
12. nguyen-2022-lung-injury-abstract.md
13. osorio-2019-nodal-signaling-abstract.md
14. pera-2002-isthmin-discovery-abstract.md
15. valle-dorado-2022-isthmin-family-abstract.md
16. valle-rios-2014-immune-cells-abstract.md
17. venugopal-2015-vascular-permeability-abstract.md
18. wang-2025-macrovascular-abstract.md
19. wu-2021-colorectal-cancer-abstract.md
20. yoshimoto-2021-cmannosylation-abstract.md
21. zhang-2011-integrin-dual-effect-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Gene/protein verification

Verification: the gene symbol 'ISM1' corresponds to Isthmin-1 (human) (kural2024kawtherameenmuhammeda pages 136-139, menghuan2023advancesinresearch pages 1-2)
Organism: Homo sapiens (Human) (kural2024kawtherameenmuhammeda pages 136-139)
Key domains: thrombospondin type 1 repeat (TSR1) and a C-terminal AMOP (adhesion-associated) domain (kural2024kawtherameenmuhammeda pages 136-139, menghuan2023advancesinresearch pages 1-2)
Protein family & synonyms: belongs to the isthmin family; synonyms include C20orf82, ISM (kural2024kawtherameenmuhammeda pages 136-139)
Caution: the symbol ISM1 can be confused with paralogs/orthologs (e.g., ISM2 or non-human ISM1); stop and verify organism and accession before using literature for functional inference (menghuan2023advancesinresearch pages 1-2)

Blockquote: A concise verification that 'ISM1' refers to human Isthmin‑1 (domains, family, synonyms) and a caution to avoid conflating with ISM2 or non‑human homologs; citations point to the primary contextual sources used.

Comprehensive research report: ISM1 (UniProt B1AKI9)

Key concepts and definitions
- Identity and structure: ISM1 (Isthmin‑1) encodes a secreted glycoprotein composed of an N‑terminal signal peptide, a central thrombospondin type 1 repeat (TSR1), and a C‑terminal AMOP domain; the human gene spans ~77.7 kb on chromosome 20p12.1 with six exons and produces a ~499 aa protein of ~60 kDa (Homo sapiens confirmed) (kural2024kawtherameenmuhammeda pages 136-139, menghuan2023advancesinresearch pages 1-2). Post‑translational modifications include N‑glycosylation (Asn28, Asn39) and C‑mannosylation (Trp223, Trp226), which regulate folding, secretion, and ER→Golgi trafficking (kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedc pages 139-142, kural2024kawtherameenmuhammedb pages 139-142). Functionally important motifs include TSR CSVTCG/WSLW and AMOP RKD/KGD (kural2024kawtherameenmuhammedb pages 136-139, kural2024kawtherameenmuhammeda pages 136-139).
- Family and domains: ISM1 belongs to the isthmin family. The TSR often mediates anti‑angiogenic and adhesion-related interactions, whereas the AMOP domain is implicated in receptor binding and cell adhesion (menghuan2023advancesinresearch pages 1-2, kural2024kawtherameenmuhammeda pages 136-139).

Cellular localization and receptors/partners
- Localization and secretion: ISM1 is a secreted protein detectable in circulation in several human studies and also binds extracellular matrix; tissue expression is prominent in lung epithelium, brain, kidney, heart, skeletal muscle, and adipocytes (adipokine role) (menghuan2023advancesinresearch pages 1-2, kural2024kawtherameenmuhammeda pages 136-139).
- Receptors and binding partners: Two principal receptor systems are supported by recent work. First, cell‑surface GRP78 (csGRP78) binds ISM1 with high affinity, mediating selective apoptosis of csGRP78high alveolar macrophages and controlling endothelial barrier function and permeability (PNAS 2022; DOI: 10.1073/pnas.2019161119) (lam2022ism1protectslung pages 1-2, kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedb pages 139-142). Second, integrins: αvβ5 has been reported as a low‑affinity ISM1 receptor linked to anti‑angiogenesis and context‑dependent adhesion signaling, while integrin α8β1 was identified as an ISM1 receptor in developing kidney mesenchyme, transmitting FAK/Akt/ERK signaling and promoting mesenchymal condensation (Nature Communications 2023; DOI: 10.1038/s41467-023-37992-x) (gao2023isthmin1(ism1)modulates pages 6-9, kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedb pages 139-142).

Primary molecular functions and pathways
- Anti‑angiogenic and apoptosis pathways: Soluble ISM1 can trigger apoptosis, either via αvβ5‑caspase‑8/3 or via csGRP78‑mediated internalization and mitochondrial dysfunction; in contrast, immobilized/ECM‑bound ISM1 can activate FAK and support adhesion/migration, underscoring context‑dependent, sometimes opposing roles (kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedc pages 139-142, kural2024kawtherameenmuhammedb pages 139-142). In the lung, ISM1–csGRP78 signaling shapes alveolar macrophage populations and limits chronic inflammation and emphysema (PNAS 2022; 10.1073/pnas.2019161119) (lam2022ism1protectslung pages 1-2).
- Metabolic signaling as an adipokine: ISM1 increases glucose uptake in adipocytes and skeletal muscle, improves glucose tolerance, suppresses hepatic lipogenesis, and stimulates hepatic protein synthesis via PI3K–Akt signaling distinct from insulin/IGF receptors, engaging mTORC2 (Akt S473) and mTORC1→S6 for protein synthesis (Cell Metabolism 2021; DOI: 10.1016/j.cmet.2021.07.010) (jiang2021isthmin1isan pages 1-3). Phosphoproteomic mapping shows ~53% overlap with insulin but hundreds of unique phospho‑events, including translational control and muscle function nodes (eLife 2022; DOI: 10.7554/eLife.80014) (zhao2022phosphoproteomicmappingreveals pages 1-1).
- Developmental morphogenesis: ISM1 is essential for early kidney development; Ism1−/− mice display impaired ureteric bud branching and mesenchyme condensation due to reduced Gdnf/Ret signaling. Mechanistically, ISM1 binds integrin α8β1 on mesenchyme, activates FAK/Akt/ERK, promotes N‑cadherin expression and aggregation, and restores GDNF/RET signaling ex vivo (Nature Communications 2023; 10.1038/s41467-023-37992-x) (gao2023isthmin1(ism1)modulates pages 6-9).

Recent developments and latest research (2023–2024 priority)
- Kidney branching via integrin α8β1: Gao et al. (2023) define ISM1 as a ligand for integrin α8β1 in kidney mesenchyme, providing precise receptor identity and downstream signaling during nephrogenesis (https://doi.org/10.1038/s41467-023-37992-x; published April 2023) (gao2023isthmin1(ism1)modulates pages 6-9).
- Clinical biomarker studies (2023–2024): Cross‑sectional human studies report altered circulating ISM1 in metabolic disease. In Chinese adults, ISM1 was higher in T2DM vs controls (median 7.78 ng/mL [IQR 6.33–9.06] vs 5.22 [3.86–6.04]; adjusted OR 4.218 [95% CI 1.843–9.653]; Diabetes, Metab Syndrome and Obesity; published July 3, 2023; https://doi.org/10.2147/dmso.s411127) (liao2023serumisthmin1was pages 1-2). In BMJ Open Diabetes Research & Care (Sept 2024), ISM1 was higher in MAFLD, T2DM, and MAFLD+T2DM vs controls (means ~1.13–1.19 vs 0.83 ng/mL), correlated positively with BMI, fasting insulin, HOMA‑IR, TC and negatively with HDL‑C; higher ISM1 quartiles tracked more metabolic syndrome components (https://doi.org/10.1136/bmjdrc-2024-004514) (lei2024serumisthmin1is pages 3-5). In individuals with obesity, ISM1 in serum tracked the subcutaneous/visceral fat ratio (SFA/VFA) measured by CT and correlated with adipose gene expression, supporting a role as a non‑invasive biomarker of abdominal fat partitioning (Cardiovascular Diabetology; Dec 2023; https://doi.org/10.1186/s12933-023-02075-0) (lopezyus2023isthmin1(ism1)a pages 6-9). In a 2024 community cohort (n=522) without diabetes, ISM1 was higher in men than women (1.74 vs 0.88 ng/mL) and, in men, each unit increase in ISM1 associated with 32% lower odds of isolated post‑challenge hyperglycemia (OR 0.68, 95% CI 0.49–0.90); adding ISM1 to a risk model improved net reclassification by 58% (Frontiers in Endocrinology; July 25, 2024; https://doi.org/10.3389/fendo.2024.1394190) (fan2024sexspecificassociationof pages 1-2).
- Field synthesis: 2024 reviews highlight ISM1 among emerging secreted regulators of glucose and lipid metabolism, emphasizing distinct signaling from canonical hormones and sex‑dependent differences in humans (Diabetologia; Aug 2024; https://doi.org/10.1007/s00125-024-06253-x) (wat2024novelsecretedregulators pages 5-7).
- Structural advance and controversy (2025 context): The first crystal structure of ISM1 (AMOP+TSR) revealed an AMOP fold reminiscent of streptavidin and reported that highly purified ISM1 did not stimulate AKT in pre‑adipocyte assays; activity in earlier studies could partly reflect co‑purifying growth factors (Nature Communications; Apr 2025; https://doi.org/10.1038/s41467-025-58828-w) (li2025crystalstructureof pages 7-8). This does not negate in vivo adipokine effects reported in 2021/2022 but introduces caution regarding assay conditions and receptor identity in adipocytes.

Current applications and real‑world implementations
- Metabolic disease biomarkers: ISM1 is measurable in serum by ELISA and associates with T2DM, MAFLD, obesity distribution, and IPH risk, with sex‑specific patterns; quantitative thresholds vary across assays/cohorts (liao2023serumisthmin1was pages 1-2, lei2024serumisthmin1is pages 3-5, lopezyus2023isthmin1(ism1)a pages 6-9, fan2024sexspecificassociationof pages 1-2).
- Respiratory disease therapeutic concept: Pulmonary delivery of recombinant ISM1 depleted pro‑inflammatory csGRP78high alveolar macrophages, reduced inflammation, and blocked emphysema progression in cigarette smoke–induced COPD mice, suggesting a translational path for inhaled rISM1 (PNAS 2022; https://doi.org/10.1073/pnas.2019161119) (lam2022ism1protectslung pages 1-2).

Expert opinions and analysis
- Pathway integration: Evidence supports ISM1 as a pleiotropic secreted factor coupling extracellular adhesion modules (TSR/AMOP) to integrin and csGRP78 systems, thereby influencing angiogenesis/permeability, immune cell apoptosis, and developmental morphogenesis. In metabolism, ISM1 engages PI3K–Akt with a signaling signature overlapping but distinct from insulin, consistent with a separate receptor system; structural work underscores the need to identify definitive adipocyte receptors and control for contaminants in biochemical assays (zhao2022phosphoproteomicmappingreveals pages 1-1, jiang2021isthmin1isan pages 1-3, li2025crystalstructureof pages 7-8).
- Context dependence: The dichotomy between soluble vs immobilized ISM1 and between GRP78 vs integrin engagement explains divergent reports (anti‑angiogenic apoptosis vs pro‑adhesive signaling). Therapeutic targeting should therefore consider ligand presentation, receptor abundance, and tissue context (kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedc pages 139-142, kural2024kawtherameenmuhammedb pages 139-142, lam2022ism1protectslung pages 1-2).

Relevant statistics and data from recent studies (selected)
- T2DM vs control: median ISM1 7.78 vs 5.22 ng/mL; adjusted OR for T2DM 4.218 (95% CI 1.843–9.653) (DMSO 2023; https://doi.org/10.2147/dmso.s411127) (liao2023serumisthmin1was pages 1-2).
- MAFLD/T2DM vs controls: mean ISM1 ~1.13–1.19 vs 0.83 ng/mL; ISM1 positively correlated with BMI, fasting insulin, HOMA‑IR, TC; negatively with HDL‑C; ISM1 quartiles associated with greater numbers of metabolic syndrome components (BMJ Open DRC 2024; https://doi.org/10.1136/bmjdrc-2024-004514) (lei2024serumisthmin1is pages 3-5).
- Obesity distribution (CT‑based): ISM1 increases across SFA/VFA ratio tertiles; serum ISM1 correlates with subcutaneous adipose expression, supporting non‑invasive biomarker potential (Cardiovasc Diabetol 2023; https://doi.org/10.1186/s12933-023-02075-0) (lopezyus2023isthmin1(ism1)a pages 6-9).
- IPH in men: per unit ISM1 associated with OR 0.68 (95% CI 0.49–0.90) for isolated post‑challenge hyperglycemia; men have higher ISM1 than women (1.74 vs 0.88 ng/mL); addition to NCDRS improved NRI by 58% (Front Endocrinol 2024; https://doi.org/10.3389/fendo.2024.1394190) (fan2024sexspecificassociationof pages 1-2).

Mechanistic highlights with URLs
- Kidney development via integrin α8β1 and GDNF/RET restoration by rIsm1 (Nat Commun 2023; https://doi.org/10.1038/s41467-023-37992-x) (gao2023isthmin1(ism1)modulates pages 6-9).
- Metabolic signaling distinct from insulin (Cell Metab 2021; https://doi.org/10.1016/j.cmet.2021.07.010) and phosphoproteomic overlap/divergence (eLife 2022; https://doi.org/10.7554/eLife.80014) (jiang2021isthmin1isan pages 1-3, zhao2022phosphoproteomicmappingreveals pages 1-1).
- Lung csGRP78‑mediated macrophage apoptosis and COPD protection (PNAS 2022; https://doi.org/10.1073/pnas.2019161119) (lam2022ism1protectslung pages 1-2).
- Structural AMOP fold and caution on adipocyte AKT assays (Nat Commun 2025; https://doi.org/10.1038/s41467-025-58828-w) (li2025crystalstructureof pages 7-8).

Embedded summary table

Table: Compact summary table of human ISM1 (UniProt B1AKI9) detailing identity, domains, receptors, localization, major pathways, structural advances, developmental roles, clinical biomarker findings (2023–2024), and therapeutic directions with primary sources cited.

Conclusions and open questions
- Verified target: ISM1 is the human secreted protein Isthmin‑1 with TSR/AMOP domains and characteristic glycosylation, acting via integrins (α8β1 in kidney; αvβ5 context‑dependently) and csGRP78. It signals through PI3K–Akt/mTOR, ERK, caspases, and Src‑junctional pathways to regulate development, vascular biology, immunity, and metabolism (gao2023isthmin1(ism1)modulates pages 6-9, lam2022ism1protectslung pages 1-2, zhao2022phosphoproteomicmappingreveals pages 1-1, jiang2021isthmin1isan pages 1-3).
- Clinical relevance: Serum ISM1 associates with T2DM, MAFLD, fat distribution, and IPH with quantifiable effect sizes in 2023–2024 studies, supporting biomarker potential. Sex‑specific patterns are emerging, particularly for post‑challenge glycemia (liao2023serumisthmin1was pages 1-2, lei2024serumisthmin1is pages 3-5, lopezyus2023isthmin1(ism1)a pages 6-9, fan2024sexspecificassociationof pages 1-2).
- Controversies and research needs: The adipocyte receptor(s) and direct signaling competence of purified ISM1 warrant clarification; structural insights into the AMOP fold provide a framework for mapping receptor epitopes and for rational therapeutic design (li2025crystalstructureof pages 7-8). Context‑dependent effects (soluble vs immobilized; GRP78 vs integrins) must be accounted for in translational applications (kural2024kawtherameenmuhammeda pages 139-142, kural2024kawtherameenmuhammedb pages 139-142, lam2022ism1protectslung pages 1-2).

References

1. (kural2024kawtherameenmuhammeda pages 136-139): B KURAL. Kawther ameen muhammed saeed aledresi1. Unknown journal, 2024.

2. (menghuan2023advancesinresearch pages 1-2): Li Menghuan, Yang Yang, Ma Qianhe, Zhang Na, Cao Shicheng, Chang Bo, and Y. I. XueJie. Advances in research of biological functions of isthmin-1. Journal of Cell Communication and Signaling, 17:507-521, Mar 2023. URL: https://doi.org/10.1007/s12079-023-00732-3, doi:10.1007/s12079-023-00732-3. This article has 20 citations and is from a peer-reviewed journal.

3. (kural2024kawtherameenmuhammeda pages 139-142): B KURAL. Kawther ameen muhammed saeed aledresi1. Unknown journal, 2024.

4. (kural2024kawtherameenmuhammedc pages 139-142): B KURAL. Kawther ameen muhammed saeed aledresi1. Unknown journal, 2024.

5. (kural2024kawtherameenmuhammedb pages 139-142): B KURAL. Kawther ameen muhammed saeed aledresi1. Unknown journal, 2024.

6. (kural2024kawtherameenmuhammedb pages 136-139): B KURAL. Kawther ameen muhammed saeed aledresi1. Unknown journal, 2024.

7. (lam2022ism1protectslung pages 1-2): Terence Y. W. Lam, Ngan Nguyen, Hong Yong Peh, Mahalakshmi Shanmugasundaram, Ritu Chandna, Jong Huat Tee, Chee Bing Ong, Md. Zakir Hossain, Shruthi Venugopal, Tianyi Zhang, Simin Xu, Tao Qiu, Wan Ting Kong, Svetoslav Chakarov, Supriya Srivastava, Wupeng Liao, Jin-Soo Kim, Ming Teh, Florent Ginhoux, W. S. Fred Wong, and Ruowen Ge. Ism1 protects lung homeostasis via cell-surface grp78-mediated alveolar macrophage apoptosis. Proceedings of the National Academy of Sciences of the United States of America, Jan 2022. URL: https://doi.org/10.1073/pnas.2019161119, doi:10.1073/pnas.2019161119. This article has 61 citations and is from a highest quality peer-reviewed journal.

8. (gao2023isthmin1(ism1)modulates pages 6-9): Ge Gao, Xiaoping Li, Zhixin Jiang, Liliana Osorio, Ying Lam Tang, Xueqing Yu, Guoxiang Jin, and Zhongjun Zhou. Isthmin-1 (ism1) modulates renal branching morphogenesis and mesenchyme condensation during early kidney development. Nature Communications, Apr 2023. URL: https://doi.org/10.1038/s41467-023-37992-x, doi:10.1038/s41467-023-37992-x. This article has 12 citations and is from a highest quality peer-reviewed journal.

9. (jiang2021isthmin1isan pages 1-3): Zewen Jiang, Meng Zhao, Laetitia Voilquin, Yunshin Jung, Mari A. Aikio, Tanushi Sahai, Florence Y. Dou, Alexander M. Roche, Ivan Carcamo-Orive, Joshua W. Knowles, Martin Wabitsch, Eric A. Appel, Caitlin L. Maikawa, Joao Paulo Camporez, Gerald I. Shulman, Linus Tsai, Evan D. Rosen, Christopher D. Gardner, Bruce M. Spiegelman, and Katrin J. Svensson. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis. Cell Metabolism, 33:1836-1852.e11, Sep 2021. URL: https://doi.org/10.1016/j.cmet.2021.07.010, doi:10.1016/j.cmet.2021.07.010. This article has 112 citations and is from a highest quality peer-reviewed journal.

10. (zhao2022phosphoproteomicmappingreveals pages 1-1): Meng Zhao, Niels Banhos Dannieskiold-Samsøe, L. Uličná, Quennie Nguyen, Laetitia Voilquin, David E. Lee, James P. White, Zewen Jiang, Nickeisha Cuthbert, Shrika Paramasivam, Ewa Bielczyk-Maczynska, Capucine Van Rechem, and Katrin J. Svensson. Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by isthmin-1. eLife, Sep 2022. URL: https://doi.org/10.7554/elife.80014, doi:10.7554/elife.80014. This article has 11 citations and is from a domain leading peer-reviewed journal.

11. (liao2023serumisthmin1was pages 1-2): Jiaxin Liao, Yuting Li, Xiaoting Gui, Yong Zhang, Xu Hu, Liang Cheng, Wen Hu, and Feng Bai. Serum isthmin-1 was increased in type 2 diabetic patients but not in diabetic sensorimotor peripheral neuropathy. Diabetes, Metabolic Syndrome and Obesity, 16:2013-2024, Jul 2023. URL: https://doi.org/10.2147/dmso.s411127, doi:10.2147/dmso.s411127. This article has 12 citations and is from a peer-reviewed journal.

12. (lei2024serumisthmin1is pages 3-5): Xiaohui Lei, HaiYan Chen, YuXin Xu, Zhuoran Yang, Lili Zhang, Cong Wang, and Hu Du. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus. BMJ Open Diabetes Research & Care, 12:e004514, Sep 2024. URL: https://doi.org/10.1136/bmjdrc-2024-004514, doi:10.1136/bmjdrc-2024-004514. This article has 7 citations and is from a peer-reviewed journal.

13. (lopezyus2023isthmin1(ism1)a pages 6-9): Marta Lopez-Yus, Carmen Casamayor, Juan Jose Soriano-Godes, Sofia Borlan, Yolanda Gonzalez-Irazabal, Maria Pilar Garcia-Sobreviela, Beatriz Garcia-Rodriguez, Raquel del Moral-Bergos, Pilar Calmarza, Jose Maria Artigas, Silvia Lorente-Cebrian, Vanesa Bernal-Monterde, Alejandro Sanz-Paris, and Jose M. Arbones-Mainar. Isthmin-1 (ism1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity. Cardiovascular Diabetology, Dec 2023. URL: https://doi.org/10.1186/s12933-023-02075-0, doi:10.1186/s12933-023-02075-0. This article has 8 citations and is from a peer-reviewed journal.

14. (fan2024sexspecificassociationof pages 1-2): Jiahua Fan, Jialin He, Jiangyuan Zhu, Jialu Yang, Jingmeng Ju, Jingyi Huang, Zhihao Huang, Zhuoyu Zhang, Wenkang Li, Min Xia, and Yan Liu. Sex-specific association of circulating isthmin-1 with isolated post-challenge hyperglycemia. Frontiers in Endocrinology, Jul 2024. URL: https://doi.org/10.3389/fendo.2024.1394190, doi:10.3389/fendo.2024.1394190. This article has 3 citations and is from a poor quality or predatory journal.

15. (wat2024novelsecretedregulators pages 5-7): Lianna W. Wat and Katrin J. Svensson. Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases. Diabetologia, 67:2626-2636, Aug 2024. URL: https://doi.org/10.1007/s00125-024-06253-x, doi:10.1007/s00125-024-06253-x. This article has 4 citations and is from a highest quality peer-reviewed journal.

16. (li2025crystalstructureof pages 7-8): Tongqing Li, Steven E. Stayrook, Wenxue Li, Yueyue Wang, Hengyi Li, Jianan Zhang, Yansheng Liu, and Daryl E. Klein. Crystal structure of isthmin-1 and reassessment of its functional role in pre-adipocyte signaling. Nature Communications, Apr 2025. URL: https://doi.org/10.1038/s41467-025-58828-w, doi:10.1038/s41467-025-58828-w. This article has 2 citations and is from a highest quality peer-reviewed journal.

Citations

1. kural2024kawtherameenmuhammeda pages 136-139
2. menghuan2023advancesinresearch pages 1-2
3. zhao2022phosphoproteomicmappingreveals pages 1-1
4. fan2024sexspecificassociationof pages 1-2
5. wat2024novelsecretedregulators pages 5-7
6. li2025crystalstructureof pages 7-8
7. kural2024kawtherameenmuhammeda pages 139-142
8. kural2024kawtherameenmuhammedc pages 139-142
9. kural2024kawtherameenmuhammedb pages 139-142
10. kural2024kawtherameenmuhammedb pages 136-139
11. IQR 6.33–9.06
12. 3.86–6.04
13. 95% CI 1.843–9.653
14. https://doi.org/10.1038/s41467-023-37992-x;
15. https://doi.org/10.2147/dmso.s411127
16. https://doi.org/10.1136/bmjdrc-2024-004514
17. https://doi.org/10.1186/s12933-023-02075-0
18. https://doi.org/10.3389/fendo.2024.1394190
19. https://doi.org/10.1007/s00125-024-06253-x
20. https://doi.org/10.1038/s41467-025-58828-w
21. https://doi.org/10.1073/pnas.2019161119
22. https://doi.org/10.1038/s41467-023-37992-x
23. https://doi.org/10.1016/j.cmet.2021.07.010
24. https://doi.org/10.7554/eLife.80014
25. https://doi.org/10.1007/s12079-023-00732-3
26. https://doi.org/10.1007/s12079-023-00732-3,
27. https://doi.org/10.1073/pnas.2019161119,
28. https://doi.org/10.1038/s41467-023-37992-x,
29. https://doi.org/10.1016/j.cmet.2021.07.010,
30. https://doi.org/10.7554/elife.80014,
31. https://doi.org/10.2147/dmso.s411127,
32. https://doi.org/10.1136/bmjdrc-2024-004514,
33. https://doi.org/10.1186/s12933-023-02075-0,
34. https://doi.org/10.3389/fendo.2024.1394190,
35. https://doi.org/10.1007/s00125-024-06253-x,
36. https://doi.org/10.1038/s41467-025-58828-w,

Introduction to ISM1 (Isthmin-1) in Humans

Isthmin-1 (ISM1) is a secreted protein encoded by the human ISM1 gene (also known as C20orf82) (www.msesupplies.com). It was originally discovered in Xenopus (frog) embryos at the midbrain–hindbrain organizer (“isthmus”), hence its name (pmc.ncbi.nlm.nih.gov). The ISM1 protein is ~50 kDa in size and is characterized by a signal peptide (for secretion) followed by two conserved domains: a thrombospondin type-1 repeat (TSR1) and an adhesion-associated domain in MUC4 and Other Proteins (AMOP) (pmc.ncbi.nlm.nih.gov) (link.springer.com). The TSR1 (~60 amino acids) is a motif often involved in cell–matrix interactions and TGF-β signaling modulation (link.springer.com). The C-terminal AMOP domain (~160 amino acids) is found only in extracellular proteins (including certain cell-adhesion molecules) and is implicated in cell adhesion and signaling (link.springer.com). These structural features immediately suggested ISM1 might function as an extracellular regulatory factor. Indeed, ISM1 is highly conserved across species – for example, the human and mouse ISM1 proteins share ~98–99% identity in the TSR1 and AMOP domains (link.springer.com) – underscoring its fundamental biological importance.

Expression and Localization: ISM1 is a secreted protein, carrying out its functions in the extracellular space. After being synthesized in the endoplasmic reticulum and Golgi, it is exported outside the cell, where it can diffuse or bind to cell surfaces and the extracellular matrix. In adult humans, ISM1 is expressed in a range of tissues, especially at barrier sites and by certain immune and metabolic cells. Profiling studies have shown high expression in skin and mucosal tissues (e.g. lung) and in subsets of immune cells (pmc.ncbi.nlm.nih.gov). Notably, natural killer (NK) cells, NKT cells, and inflammatory T-cells (Th17 lineage) produce ISM1 (pmc.ncbi.nlm.nih.gov). Its expression in CD4 T-cells is enhanced under Th17-polarizing conditions and suppressed by interferon-γ, suggesting cytokine-regulated expression in immune responses (pmc.ncbi.nlm.nih.gov). ISM1 is also produced by adipose tissue; in fact, it has been identified as an adipokine, a hormone secreted by fat cells (pmc.ncbi.nlm.nih.gov). Circulating ISM1 has been detected in human serum, and recent clinical studies have begun to correlate ISM1 levels with metabolic conditions (for example, higher ISM1 in gestational diabetes and in diabetic albuminuria) (www.ncbi.nlm.nih.gov). Within the body, ISM1 predominantly operates outside cells, binding to specific cell-surface targets (receptors or matrix components) to influence cell behavior. This extracellular mode of action distinguishes ISM1 from intracellular enzymes or structural proteins – it functions as a secreted signaling/regulatory factor. Below, we discuss the known functions of ISM1 in key biological processes, the pathways it influences, and where it carries out these roles, based on current research.

Developmental Functions of ISM1

Role in Embryogenesis: ISM1 has critical functions during early development. It is dynamically expressed in embryos with distinct spatial patterns, hinting at regulatory roles in tissue morphogenesis (pubmed.ncbi.nlm.nih.gov). In Xenopus and chick embryos, ISM1 is highly expressed in organizer regions such as the anterior primitive streak and midbrain-hindbrain boundary during gastrulation (pubmed.ncbi.nlm.nih.gov). One major role of ISM1 in development is the modulation of TGF-β family signaling, specifically the Nodal pathway that controls left-right (L–R) body asymmetry. Experiments have shown that ISM1 acts as an inhibitor of Nodal signaling: it binds directly to Nodal (a TGF-β ligand) and to the Activin receptor ACVR1B (ALK4) via its AMOP domain, preventing Nodal from activating its receptors (pubmed.ncbi.nlm.nih.gov). ISM1 does not broadly block TGF-β/Activin signals – notably it had little effect on TGF-β1, Activin-A, or BMP4 pathways – but it specifically suppresses Nodal-induced SMAD2 phosphorylation (pubmed.ncbi.nlm.nih.gov). Consistent with this, experimental over-expression of ISM1 in chick embryos caused disruptive L–R patterning: treated embryos developed abnormal left-right asymmetry and mis-positioned hearts (pubmed.ncbi.nlm.nih.gov). These findings demonstrate that ISM1’s primary developmental function is as a Nodal antagonist that helps refine embryonic patterning signals. By binding Nodal and its receptor, ISM1 can locally dampen Nodal activity, which is essential for correct asymmetric organ development (pubmed.ncbi.nlm.nih.gov). This mechanism has been proposed to ensure proper heart looping and organ positioning during embryogenesis.

Beyond left-right axis formation, ISM1 may influence other developmental processes. It is co-expressed with key morphogens (for instance, fibroblast growth factor 8) in organizer regions (link.springer.com), suggesting it might interact with or modulate additional signaling centers in the embryo. In zebrafish, ISM1 is essential for normal blood development: knockdown of ism1 impairs the formation of hematopoietic stem and progenitor cells, leading to reduced production of blood lineages (fewer neutrophils, macrophages, and erythrocytes) (pubmed.ncbi.nlm.nih.gov). Morpholino experiments in zebrafish showed that loss of ISM1 disrupts the generation of these stem cells in the embryonic aorta, indicating ISM1 normally supports hematopoietic niche or signaling factors necessary for blood stem cell emergence (pubmed.ncbi.nlm.nih.gov). Although the precise downstream pathway is not fully defined, this conserved requirement points to ISM1 as a growth factor in developmental contexts like hematopoiesis. Taken together, evidence from multiple model organisms highlights ISM1 as a multifunctional embryonic factor. It helps orchestrate developmental signaling pathways – particularly the Nodal/TGF-β pathway – that pattern the early embryo, and it supports the proper formation of organs and cell lineages. These developmental roles are executed extracellularly: ISM1 is secreted by embryonic organizer tissues and acts in the extracellular milieu by binding to growth factor ligands or receptors on cell surfaces (e.g. Nodal and ACVR1B) to modulate signaling (pubmed.ncbi.nlm.nih.gov).

ISM1 in Angiogenesis and Cell Survival

One of the most well-characterized functions of ISM1 is its role as an angiogenesis inhibitor and pro-apoptotic factor in the extracellular environment. ISM1 has potent effects on blood vessel growth: it was identified as a novel secreted anti-angiogenic protein that can block new capillary formation and induce endothelial cell death (link.springer.com) (pubmed.ncbi.nlm.nih.gov). In a landmark study, Xiang et al. (2011) showed that recombinant ISM1 or its isolated C-terminal domain could inhibit endothelial tube formation in vitro and suppress angiogenesis in vivo. When added to cultured endothelial cells, ISM1 (especially the C-terminal AMOP segment) bound to cell surfaces and blocked capillary network formation in a dose- and time-dependent manner, impairing the cells’ migration, adhesion, and survival (link.springer.com). In a mouse model, ISM1 administration dose-dependently inhibited growth-factor–induced neovascularization, demonstrating its anti-angiogenic efficacy in vivo (link.springer.com). Complementing these findings, overexpression of ISM1 in tumor cells strongly suppressed tumor vascularization and growth in mouse xenograft models (pubmed.ncbi.nlm.nih.gov). These experiments establish ISM1 as an endogenous inhibitor of angiogenesis with natural anti-tumor properties.

Mechanisms – Integrin and GRP78 Binding: Molecular studies have elucidated how ISM1, acting outside the cell, triggers apoptosis in endothelial and other cells. ISM1 engages at least two classes of cell-surface molecules: integrins and the receptor/chaperone GRP78 (78 kDa glucose-regulated protein). Integrin αvβ5 on endothelial cells was identified as a low-affinity receptor for ISM1 (pubmed.ncbi.nlm.nih.gov). The ISM1 protein contains an RGD/RKD sequence within its AMOP domain that is predicted to bind integrins (link.springer.com), and indeed ISM1–integrin binding can initiate intracellular signals. For example, ISM1 ligation of αvβ5 integrin on endothelial cells was reported to activate caspase-3 and induce apoptosis (link.springer.com). However, integrin binding alone did not fully explain ISM1’s potent effects. Researchers discovered that ISM1 also targets cell-surface GRP78 as a high-affinity receptor (binding K_d ≈ 8.6 nM) (pubmed.ncbi.nlm.nih.gov). GRP78 (also called BiP) is normally an ER chaperone, but under stress conditions it is often displayed on the plasma membrane of endothelial cells, cancer cells, and some lymphocytes (link.springer.com). Chen et al. (2014) showed that ISM1 binds to exposed GRP78 on target cells, which triggers ISM1 internalization via clathrin-mediated endocytosis and leads to apoptosis (pubmed.ncbi.nlm.nih.gov) (link.springer.com). Once ISM1 is bound to GRP78, the complex is taken into the cell and co-trafficked to the mitochondria (pubmed.ncbi.nlm.nih.gov). Inside the cell, ISM1 localizes to the mitochondrial inner membrane, where it interacts with the adenine nucleotide transporter (ANT) – a carrier that exchanges ADP/ATP across the mitochondrial membrane (link.springer.com). ISM1 essentially blocks ATP export from mitochondria, causing ATP to accumulate in mitochondria and cytosolic energy levels to plummet (link.springer.com). This energetic shutdown activates the intrinsic apoptotic pathway: loss of ATP and mitochondrial dysfunction lead to caspase activation (including caspase-8 and -3) and cell death (link.springer.com) (link.springer.com). Importantly, ISM1’s targeting of GRP78 provides selectivity for stressed or abnormal cells – normal healthy cells express little surface GRP78 and are relatively resistant to ISM1-induced apoptosis (pubmed.ncbi.nlm.nih.gov). In contrast, activated endothelial cells or cancer cells (which upregulate surface GRP78 under tumor and hypoxic stress) are highly susceptible to ISM1’s pro-apoptotic effect (pubmed.ncbi.nlm.nih.gov). Thus, ISM1 acts as a context-dependent “cell death ligand” in the extracellular space, honing in on pathological cells and inducing apoptosis via a unique internalization-to-mitochondria mechanism. This mechanism underlies ISM1’s angiogenesis inhibition (it prunes proliferating blood vessel cells by apoptosis) and its anti-cancer activity by cutting off tumor blood supply and even directly killing tumor cells that express surface GRP78 (pubmed.ncbi.nlm.nih.gov) (link.springer.com).

Beyond endothelial cells, ISM1’s ability to trigger cell death may extend to other contexts. For instance, recent work implicates ISM1 in kidney disease: ISM1 was found to be upregulated in models of glomerulosclerosis, and exposure of kidney podocyte cells to ISM1 reduced their viability and induced apoptosis in vitro (pmc.ncbi.nlm.nih.gov). Low doses of ISM1 activated caspases in cultured podocytes, while higher doses caused mitochondrial membrane depolarization and nuclear translocation of apoptosis-inducing factor (AIF), indicative of severe mitochondrial injury (pmc.ncbi.nlm.nih.gov). These observations suggest that aberrant ISM1 expression can contribute to tissue injury (in this case, podocyte loss and proteinuric kidney disease) through the same apoptosis pathway identified in endothelial cells. In cancer biology, there are also indications that ISM1 might influence the immune microenvironment of tumors. A 2021 study found that ISM1 expression correlates with upregulation of immunosuppressive molecules (like the checkpoint receptors TIM-3 and CTLA-4) in certain cancers (link.springer.com). This raises the possibility that ISM1 could dampen anti-tumor immune responses, although more research is needed to clarify this role. In summary, ISM1 functions extracellularly as a multifaceted regulator of cell survival: it can limit pathological angiogenesis and tumor growth by directly inducing apoptosis of endothelial or tumor cells, and it might indirectly shape immune or inflammatory environments in disease. The key molecular players in these processes are cell-surface integrins and GRP78, which serve as ISM1’s entry points to execute its pro-apoptotic program outside-in.

Metabolic Role of ISM1 as an Adipokine

In addition to developmental and anti-angiogenic functions, ISM1 has emerged as a hormone-like factor in metabolism. In 2021, Jiang et al. reported ISM1 as a novel adipokine involved in glucose and lipid homeostasis (pmc.ncbi.nlm.nih.gov). Adipose (fat) tissue was found to secrete ISM1, and this secreted ISM1 acts on other tissues to regulate metabolic processes. Notably, ISM1 can enhance glucose uptake into adipocytes and improve systemic glucose tolerance (pmc.ncbi.nlm.nih.gov). Mice lacking ISM1 (germline knockout models) showed impaired glucose handling – they had reduced basal and insulin-stimulated glucose uptake in adipose tissue, developed worse glucose intolerance, and exhibited decreased insulin sensitivity (pmc.ncbi.nlm.nih.gov). These phenotypes indicate that endogenous ISM1 normally promotes insulin-responsive glucose disposal. Strikingly, ISM1 was shown to trigger the PI3K–Akt signaling pathway in adipose tissue independently of the insulin receptor (pmc.ncbi.nlm.nih.gov). In other words, ISM1 can activate the same key downstream pathway as insulin (PI3K/Akt, which drives glucose uptake) but does so via a distinct receptor mechanism that does not involve the insulin or IGF-1 receptors (pmc.ncbi.nlm.nih.gov). This insulin-independent route is significant because it means ISM1 can stimulate glucose uptake even when insulin signaling is impaired. Mechanistically, although the exact receptor for ISM1 in metabolic tissues remains to be identified, the outcome is clear: ISM1 binding on adipocytes triggers PI3K and Akt phosphorylation, leading to increased glucose transporter activity and glucose uptake into the cells (pmc.ncbi.nlm.nih.gov). In this way, ISM1 acts as an “insulin-like” hormone in adipose tissue, augmenting glucose clearance from the blood (pubmed.ncbi.nlm.nih.gov).

Importantly, ISM1’s metabolic effects are not a mere duplicate of insulin – ISM1 has distinct actions on lipid metabolism that complement its glucose-lowering function. While insulin tends to promote lipogenesis (fat storage) in the liver, ISM1 does the opposite. The presence of ISM1 shifts hepatocytes from a lipid-storage program to a protein-synthesis program, thereby inhibiting hepatic lipid synthesis and accumulation (pmc.ncbi.nlm.nih.gov). In experimental models, ISM1 treatment reduced triglyceride accumulation in liver cells, alleviating fatty liver changes. This dual action – increasing peripheral glucose uptake and reducing liver fat – positions ISM1 as a beneficial metabolic regulator. Indeed, in obese diabetic mice, therapeutic administration of recombinant ISM1 significantly improved hyperglycemia and enhanced insulin sensitivity, while also ameliorating hepatic steatosis (fatty liver) (pmc.ncbi.nlm.nih.gov). For example, mice on a high-fat diet treated with ISM1 had lower blood glucose levels and less fat buildup in the liver compared to controls (pmc.ncbi.nlm.nih.gov). These findings were described as revealing “an unexpected, bioactive protein hormone” with potential to tackle both diabetes and fatty liver disease simultaneously (pmc.ncbi.nlm.nih.gov). In essence, ISM1 functions as a metabolic hormone that links adipose tissue to systemic energy regulation. It carries out this role in the extracellular space by circulating from fat to target organs: in adipose tissue it acts in an autocrine/paracrine fashion to enhance glucose uptake, and in the liver it likely binds to cell-surface receptors that alter metabolic signaling, tilting the balance away from fat storage (pmc.ncbi.nlm.nih.gov). The discovery of ISM1’s metabolic role is quite recent, and ongoing research is focused on identifying its receptor and understanding how it integrates into known metabolic pathways. Nevertheless, its ability to activate PI3K–Akt without engaging the insulin receptor marks it as a unique lever in glucose metabolism. Additionally, its insulin-sensitizing and lipid-lowering effects have attracted interest in ISM1 as a therapeutic target for metabolic disorders. Experts note that harnessing ISM1 or its pathway could lead to treatments that improve glycemic control without the side effect of promoting fat storage (pmc.ncbi.nlm.nih.gov) (www.frontiersin.org).

Other Biological Roles and Emerging Insights

Beyond the major roles described above, ISM1 appears to have ancillary functions in immune regulation and tissue homeostasis, though these are still being elucidated. The presence of ISM1 in skin and mucosal sites, and its induction in Th17 cells, suggests it may contribute to barrier immunity or inflammation (pmc.ncbi.nlm.nih.gov). A recent study in fish provides evidence that ISM1 can act as an innate immune modulator: in zebrafish, ISM1 expression was shown to limit viral replication and promote antiviral responses by enhancing the production of interferons and antiviral genes via the TBK1–IRF3 signaling pathway (www.frontiersin.org). In that model, increasing ISM1 led to higher interferon (IFN) levels and up-regulation of antiviral effectors like Mx, thereby helping the host control infection (www.frontiersin.org). This finding hints that ISM1 might function as a conserved antiviral factor, perhaps by serving as a danger signal or by influencing cytokine signaling in infected tissues. Whether human ISM1 plays a similar role in antiviral defense or inflammation is an area of active inquiry. Its expression by NK cells and certain T-cells could mean ISM1 participates in the crosstalk between immune cells and the vasculature or epithelium during inflammation. Interestingly, because ISM1 can induce apoptosis via GRP78, there is speculation that immune cells secreting ISM1 might use it to eliminate nearby cells (for instance, NK cells might secrete ISM1 to help kill tumor endothelial cells or infected cells expressing surface GRP78). Some researchers have also noted that ISM1 can influence inflammatory signaling pathways. For example, ISM1 has been linked to changes in the expression of inflammatory cytokines and checkpoint molecules in cancer models (link.springer.com) (link.springer.com). Although details remain to be worked out, ISM1 could thus be involved in immune suppression or activation depending on context, making it a potentially important mediator in the tumor microenvironment or autoimmune settings.

From a clinical standpoint, these diverse activities make ISM1 relevant to multiple diseases. Its role in cancer is double-edged: on one hand ISM1 is anti-angiogenic and pro-apoptotic to tumors (a desirable therapeutic trait), but tumors might also exploit ISM1’s apoptosis pathway to evade immune attack (if, for example, tumor-derived ISM1 suppressed immune cell function) (link.springer.com) (www.frontiersin.org). Nonetheless, the prevailing view is that ISM1 or its functional peptides could be harnessed as anti-cancer agents. A cyclic peptide derived from the ISM1 AMOP domain (termed “BC71”) has already been tested: it binds cell-surface GRP78 and mimics ISM1’s apoptotic effect, activating p53 and caspase-8 to kill endothelial and cancer cells (link.springer.com) (link.springer.com). In mice, this peptide inhibited angiogenesis and tumor growth without systemic toxicity in early studies (link.springer.com) (link.springer.com). Such approaches underscore ISM1’s therapeutic potential. Likewise in metabolic disease, ISM1 is being explored as a therapeutic target or biomarker. As noted, raising ISM1 levels in mice improved diabetes and fatty liver outcomes (pmc.ncbi.nlm.nih.gov). However, human data are still preliminary. A 2022 review highlighted that no clinical trials have yet evaluated ISM1 therapy in humans and suggested this as a promising research direction (www.frontiersin.org). Observational studies have measured ISM1 in patient sera: one report found elevated ISM1 in people with obesity and a correlation with visceral fat distribution, hinting that ISM1 might reflect or influence adipose tissue function . Another study noted higher ISM1 levels in gestational diabetes, proposing ISM1 as a potential biomarker for metabolic stress in pregnancy (www.ncbi.nlm.nih.gov). These clinical correlations need further validation, but they align with ISM1’s identified role in metabolism.

Conclusion and Outlook

In summary, ISM1 (Isthmin-1) is a multifunctional secreted protein that plays diverse roles in human biology, from guiding embryonic development to regulating blood vessel growth, immune responses, and metabolism. At its core, ISM1’s primary function is to act as an extracellular mediator that binds specific targets (growth factors, receptors, or integrins) and thereby modulates key signaling pathways. In embryos, ISM1 is a precise inhibitor of Nodal/TGF-β signals, ensuring proper left-right patterning and contributing to organogenesis (pubmed.ncbi.nlm.nih.gov). In the vascular system, ISM1 serves as a context-dependent pro-apoptotic factor, targeting surface GRP78 to trigger endothelial and tumor cell apoptosis, which in turn inhibits pathological angiogenesis (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). As a hormone, ISM1 functions as an insulin-independent metabolic regulator, activating PI3K–Akt signaling in adipose tissue to promote glucose uptake and concurrently protecting against fatty liver by restraining lipogenesis (pmc.ncbi.nlm.nih.gov). These roles are carried out in the extracellular space – whether in the interstitial matrix of developing tissues, the bloodstream near insulin-sensitive organs, or the tumor microenvironment, ISM1 exerts its effects by binding outside of cells and transducing signals inward. This extrinsic mode of action is a unifying theme, even though the outcomes differ by context (developmental patterning vs. apoptosis vs. metabolism).

Crucially, experimental evidence underpins each of these functions: loss-of-function and gain-of-function studies in animals have demonstrated ISM1’s importance (e.g. chick embryo experiments for L-R asymmetry (pubmed.ncbi.nlm.nih.gov), zebrafish morphants for hematopoiesis (pubmed.ncbi.nlm.nih.gov), mouse knockouts for glucose homeostasis (pmc.ncbi.nlm.nih.gov), and xenograft models for angiogenesis (pubmed.ncbi.nlm.nih.gov)). Biochemical assays and structural inferences have identified how ISM1 engages with its partners – for example, the presence of a TSR1 domain foreshadowed TGF-β pathway involvement (link.springer.com), and indeed ISM1 specifically binds the Nodal ligand to modulate that pathway (pubmed.ncbi.nlm.nih.gov). Similarly, the AMOP domain contains an RGD-like motif, and ISM1 was found to bind an RGD-binding integrin (αvβ5) on endothelial cells (link.springer.com). The discovery of surface GRP78 as an ISM1 receptor was informed by the notion that ISM1 induces apoptosis selectively in stressed cells; this led researchers to identify GRP78 – a stress-inducible surface protein – as the high-affinity interaction that explains ISM1’s selective toxicity (pubmed.ncbi.nlm.nih.gov). Such structure-function relationships continue to be an area of interest, as scientists seek to determine if ISM1’s metabolic receptor is another integrin, a signaling co-receptor, or an unknown receptor that connects ISM1 to PI3K activation.

Given ISM1’s involvement in critical pathways, current research is highly active (especially in the past few years). Reviews in 2023–2024 describe ISM1 as a “multifunctional secreted protein” at the intersection of development, angiogenesis, metabolism, and immunity (pubmed.ncbi.nlm.nih.gov). Its ability to regulate cell proliferation, migration, and the immune milieu in cancer has been highlighted, as has its role as a newly identified insulin-like adipokine (pubmed.ncbi.nlm.nih.gov). Experts in the field (Liang et al., 2024) note that while much progress has been made, “the biological function of ISM-1 remains largely unknown” in the sense that new roles may yet be discovered and the full molecular network of ISM1’s action is not fully mapped (pubmed.ncbi.nlm.nih.gov). Moving forward, key questions include identifying the receptors and signaling cascades through which ISM1 operates in metabolic tissues and immune cells, understanding how ISM1 expression is regulated in various physiological and disease states, and exploring therapeutic applications. There is optimism that harnessing ISM1 could lead to novel treatments: for instance, ISM1 or its analogs might be used to starve tumors of blood vessels or to improve metabolic syndrome without the side-effects of excess insulin (pmc.ncbi.nlm.nih.gov) (www.frontiersin.org). In summary, ISM1 is a compelling example of a gene product with pleiotropic yet well-defined functions – a secreted adapter that links developmental cues, vascular homeostasis, and metabolic control. Ongoing research, armed with precise structural and functional studies, is expected to fully elucidate ISM1’s role in human biology and disease, potentially translating this knowledge into clinical interventions in the future (pubmed.ncbi.nlm.nih.gov) (www.frontiersin.org).

References: (Key studies and reviews are cited in text above, with publication year and DOI/PubMed where available.)

Citations

1. AnnotationURLCitation(end_index=341, start_index=149, title='ISM1 Polyclonal Antibody Reactivity Mouse', type='url_citation', url='https://www.msesupplies.com/en-de/products/ism1-polyclonal-antibody-reactivity-mouse#:~:text=ISM1%20Polyclonal%20Antibody%20Reactivity%20Mouse,B1AKI9%20Calculated%20MW')
2. AnnotationURLCitation(end_index=615, start_index=464, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=expressed%20in%20skin%2C%20mucosal%20tissues%2C,The%20presence%20of')
3. AnnotationURLCitation(end_index=1014, start_index=863, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=expressed%20in%20skin%2C%20mucosal%20tissues%2C,The%20presence%20of')
4. AnnotationURLCitation(end_index=1149, start_index=1015, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=thrombospondin%20type%201%20repeat%20,2004')
5. AnnotationURLCitation(end_index=1435, start_index=1263, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=Studies%20have%20shown%20that%20the,only%20found%20in%20extracellular%20proteins')
6. AnnotationURLCitation(end_index=1747, start_index=1616, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=The%20AMOP%20structural%20domain%20is,C')
7. AnnotationURLCitation(end_index=2182, start_index=2005, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=The%20two%20structural%20domains%20of,African%20clawed%20frog%20respectively%2C%20and')
8. AnnotationURLCitation(end_index=2938, start_index=2785, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=predicted%20%E2%88%BC50,lymphocyte%20effector%20functions%20and%20may')
9. AnnotationURLCitation(end_index=3197, start_index=3044, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=predicted%20%E2%88%BC50,lymphocyte%20effector%20functions%20and%20may')
10. AnnotationURLCitation(end_index=3527, start_index=3367, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=ISM1%20in%20both%20human%20and,lymphocyte%20effector%20functions%20and%20may')
11. AnnotationURLCitation(end_index=3828, start_index=3655, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Here%2C%20Zewen%20Jiang%20et%20al,therapeutic%20opportunity%20to%20simultaneously%20treat')
12. AnnotationURLCitation(end_index=4168, start_index=4050, title='ISM1 isthmin 1 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/140862#:~:text=2,PMID%2036126993%2C%20Free%20PMC%20Article')
13. AnnotationURLCitation(end_index=5080, start_index=4911, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=Distinct%20spatiotemporal%20expression%20of%20isthmin,to%20a%20better%20understanding%20of')
14. AnnotationURLCitation(end_index=5399, start_index=5250, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=in%20Xenopus%20laevis%20embryonic%20brain%2C,Mechanistically%2C%20ISM1')
15. AnnotationURLCitation(end_index=5961, start_index=5802, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,ACVR1B%20through%20its%20AMOP%20domain')
16. AnnotationURLCitation(end_index=6304, start_index=6158, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,Mechanistically%2C%20ISM1')
17. AnnotationURLCitation(end_index=6650, start_index=6498, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=inhibitor%20of%20NODAL%20signaling,ACVR1B%20through%20its%20AMOP%20domain')
18. AnnotationURLCitation(end_index=7093, start_index=6934, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,ACVR1B%20through%20its%20AMOP%20domain')
19. AnnotationURLCitation(end_index=7549, start_index=7393, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=important%20signaling%20factor%20mediating%20MHB,8%20genes%20are')
20. AnnotationURLCitation(end_index=8075, start_index=7892, title='Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29758043/#:~:text=numbers%20of%20neutrophils%2C%20macrophages%2C%20and,investigated%20for%20potential%20clinical%20utility')
21. AnnotationURLCitation(end_index=8504, start_index=8321, title='Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29758043/#:~:text=numbers%20of%20neutrophils%2C%20macrophages%2C%20and,investigated%20for%20potential%20clinical%20utility')
22. AnnotationURLCitation(end_index=9397, start_index=9238, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,ACVR1B%20through%20its%20AMOP%20domain')
23. AnnotationURLCitation(end_index=9964, start_index=9789, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=length%20ISM1%20protein%2C%20ISM1,5%C2%A0%CE%BCM%20and%201%C2%A0%CE%BCM%20of%20ISM1')
24. AnnotationURLCitation(end_index=10089, start_index=9965, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=Isthmin%20,this%20work%2C%20we%20report%20the')
25. AnnotationURLCitation(end_index=10715, start_index=10534, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=and%20angiogenesis%20%28Zhang%20et%20al,5%C2%A0%CE%BCM%20and%201%C2%A0%CE%BCM%20of%20ISM1')
26. AnnotationURLCitation(end_index=11050, start_index=10875, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=length%20ISM1%20protein%2C%20ISM1,5%C2%A0%CE%BCM%20and%201%C2%A0%CE%BCM%20of%20ISM1')
27. AnnotationURLCitation(end_index=11327, start_index=11203, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=Isthmin%20,this%20work%2C%20we%20report%20the')
28. AnnotationURLCitation(end_index=11986, start_index=11842, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=cell%20%28EC%29%20apoptosis,Normal%20cells%20and%20benign%20tumor')
29. AnnotationURLCitation(end_index=12224, start_index=12093, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=The%20AMOP%20structural%20domain%20is,C')
30. AnnotationURLCitation(end_index=12582, start_index=12416, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=ISM1%20binds%20to%20av%CE%B25%20and,8%20signaling%2C%20causing%20apoptosis')
31. AnnotationURLCitation(end_index=12950, start_index=12793, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=affinity%20receptor%20for%20ISM%2C%20the,Normal%20cells%20and%20benign%20tumor')
32. AnnotationURLCitation(end_index=13283, start_index=13135, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=protein%2C%20GRP78%2C%20promotes%20proper%20protein,Chen')
33. AnnotationURLCitation(end_index=13607, start_index=13460, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=identification%20of%20cell,membrane%20and%20blocks%20ATP%20transport')
34. AnnotationURLCitation(end_index=13755, start_index=13608, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=2003%20%3B%20Tsai%20et%20al,level%20of%20ATP%20in%20the')
35. AnnotationURLCitation(end_index=14009, start_index=13859, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=cells%20tend%20to%20express%20low,GRP78%20to%20trigger%20apoptosis%20by')
36. AnnotationURLCitation(end_index=14350, start_index=14218, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=soluble%20ISM1%20binds%20to%20GRP78%2C,3')
37. AnnotationURLCitation(end_index=14623, start_index=14491, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=soluble%20ISM1%20binds%20to%20GRP78%2C,3')
38. AnnotationURLCitation(end_index=14971, start_index=14805, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=ISM1%20binds%20to%20av%CE%B25%20and,8%20signaling%2C%20causing%20apoptosis')
39. AnnotationURLCitation(end_index=15073, start_index=14972, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=et%20al,3')
40. AnnotationURLCitation(end_index=15420, start_index=15273, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=identification%20of%20cell,membrane%20and%20blocks%20ATP%20transport')
41. AnnotationURLCitation(end_index=15748, start_index=15601, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=identification%20of%20cell,membrane%20and%20blocks%20ATP%20transport')
42. AnnotationURLCitation(end_index=16337, start_index=16198, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=cell%20%28EC%29%20apoptosis,and%20are%20resistant%20to%20ISM')
43. AnnotationURLCitation(end_index=16485, start_index=16338, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=2003%20%3B%20Tsai%20et%20al,level%20of%20ATP%20in%20the')
44. AnnotationURLCitation(end_index=16976, start_index=16814, title='The Angiogenesis Inhibitor Isthmin-1 (ISM1) Is Overexpressed in Experimental Models of Glomerulopathy and Impairs the Viability of Podocytes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9916724/#:~:text=with%20low%20doses%20of%20recombinant,in%20the%20progression%20of%20glomerular')
45. AnnotationURLCitation(end_index=17368, start_index=17206, title='The Angiogenesis Inhibitor Isthmin-1 (ISM1) Is Overexpressed in Experimental Models of Glomerulopathy and Impairs the Viability of Podocytes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9916724/#:~:text=with%20low%20doses%20of%20recombinant,in%20the%20progression%20of%20glomerular')
46. AnnotationURLCitation(end_index=17996, start_index=17871, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=match%20at%20L706%20T,mesenchymal')
47. AnnotationURLCitation(end_index=19034, start_index=18861, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Here%2C%20Zewen%20Jiang%20et%20al,therapeutic%20opportunity%20to%20simultaneously%20treat')
48. AnnotationURLCitation(end_index=19412, start_index=19262, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=we%20identify%20Isthmin,Furthermore%2C%20therapeutic%20dosing%20of')
49. AnnotationURLCitation(end_index=19805, start_index=19655, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=we%20identify%20Isthmin,Furthermore%2C%20therapeutic%20dosing%20of')
50. AnnotationURLCitation(end_index=20210, start_index=20042, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20ablation%20results%20in%20impaired,induced%20obese%20mice%20and%20ameliorates')
51. AnnotationURLCitation(end_index=20561, start_index=20428, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20in%20glucose%20regulation,These%20findings')
52. AnnotationURLCitation(end_index=21142, start_index=20974, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20ablation%20results%20in%20impaired,induced%20obese%20mice%20and%20ameliorates')
53. AnnotationURLCitation(end_index=21423, start_index=21263, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=development%20of%20cancer%20by%20regulating,1%20remains%20largely%20unknown.%20In')
54. AnnotationURLCitation(end_index=22017, start_index=21860, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20in%20glucose%20regulation,diabetes%20and%20fatty%20liver%20disease')
55. AnnotationURLCitation(end_index=22626, start_index=22488, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=receptors,hormone%20that%20might%20have%20simultaneous')
56. AnnotationURLCitation(end_index=22907, start_index=22769, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=receptors,hormone%20that%20might%20have%20simultaneous')
57. AnnotationURLCitation(end_index=23238, start_index=23073, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=lipogenic%20to%20a%20protein%20synthesis,diabetes%20and%20fatty%20liver%20disease')
58. AnnotationURLCitation(end_index=23807, start_index=23665, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20ablation%20results%20in%20impaired,These%20findings')
59. AnnotationURLCitation(end_index=24591, start_index=24434, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20in%20glucose%20regulation,diabetes%20and%20fatty%20liver%20disease')
60. AnnotationURLCitation(end_index=24806, start_index=24592, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=have%20evaluated%20the%20therapeutic%20potential,goal%20for%20the%20near%20future')
61. AnnotationURLCitation(end_index=25329, start_index=25176, title='Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4186767/#:~:text=predicted%20%E2%88%BC50,lymphocyte%20effector%20functions%20and%20may')
62. AnnotationURLCitation(end_index=25827, start_index=25627, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=ISM1%20might%20be%20a%20new,expression%20of%20ISM1%20in%20zebrafish')
63. AnnotationURLCitation(end_index=26191, start_index=25991, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=ISM1%20might%20be%20a%20new,expression%20of%20ISM1%20in%20zebrafish')
64. AnnotationURLCitation(end_index=27305, start_index=27145, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=of%20multiple%20organs,relevant%20research%20results%20from%20recent')
65. AnnotationURLCitation(end_index=27454, start_index=27306, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=protein%2C%20GRP78%2C%20promotes%20proper%20protein,Chen')
66. AnnotationURLCitation(end_index=28214, start_index=28066, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=protein%2C%20GRP78%2C%20promotes%20proper%20protein,Chen')
67. AnnotationURLCitation(end_index=28422, start_index=28215, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=that%20ISM1%20may%20be%20a,potential%20therapeutic%20target%20for%20cancer')
68. AnnotationURLCitation(end_index=28936, start_index=28769, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=addition%2C%20BC71%20in%20the%20AMOP,8%20signaling%2C%20causing%20apoptosis')
69. AnnotationURLCitation(end_index=29115, start_index=28937, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=Additionally%2C%20a%20novel%20cyclic%20peptide%2C,to%20cause%20apoptosis%20in%20cancer')
70. AnnotationURLCitation(end_index=29388, start_index=29222, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=ISM1%20binds%20to%20av%CE%B25%20and,8%20signaling%2C%20causing%20apoptosis')
71. AnnotationURLCitation(end_index=29536, start_index=29389, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=2003%20%3B%20Tsai%20et%20al,level%20of%20ATP%20in%20the')
72. AnnotationURLCitation(end_index=29906, start_index=29772, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=receptors,diabetes%20and%20fatty%20liver%20disease')
73. AnnotationURLCitation(end_index=30310, start_index=30096, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=have%20evaluated%20the%20therapeutic%20potential,goal%20for%20the%20near%20future')
74. AnnotationURLCitation(end_index=30817, start_index=30688, title='ISM1 isthmin 1 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/140862#:~:text=1,positively%20and%20independently%20correlated%20with')
75. AnnotationURLCitation(end_index=31669, start_index=31510, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,ACVR1B%20through%20its%20AMOP%20domain')
76. AnnotationURLCitation(end_index=32045, start_index=31878, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=affinity%20receptor%20for%20ISM%2C%20the,essential%20for%20its%20proapoptotic%20activity')
77. AnnotationURLCitation(end_index=32196, start_index=32046, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=cells%20tend%20to%20express%20low,GRP78%20to%20trigger%20apoptosis%20by')
78. AnnotationURLCitation(end_index=32569, start_index=32427, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=Ism1%20ablation%20results%20in%20impaired,These%20findings')
79. AnnotationURLCitation(end_index=33371, start_index=33219, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=inhibitor%20of%20NODAL%20signaling,ACVR1B%20through%20its%20AMOP%20domain')
80. AnnotationURLCitation(end_index=33594, start_index=33411, title='Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29758043/#:~:text=numbers%20of%20neutrophils%2C%20macrophages%2C%20and,investigated%20for%20potential%20clinical%20utility')
81. AnnotationURLCitation(end_index=33786, start_index=33636, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=we%20identify%20Isthmin,Furthermore%2C%20therapeutic%20dosing%20of')
82. AnnotationURLCitation(end_index=33950, start_index=33826, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=Isthmin%20,this%20work%2C%20we%20report%20the')
83. AnnotationURLCitation(end_index=34290, start_index=34133, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=Stuelten%20and%20Zhang%202021%29,found%20that%20ISM1%20caused%20a')
84. AnnotationURLCitation(end_index=34528, start_index=34369, title='ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31171630/#:~:text=embryo%2C%20suggested%20that%20ISM1%20may,ACVR1B%20through%20its%20AMOP%20domain')
85. AnnotationURLCitation(end_index=34795, start_index=34664, title='Advances in research of biological functions of Isthmin-1 | Journal of Cell Communication and Signaling', type='url_citation', url='https://link.springer.com/article/10.1007/s12079-023-00732-3#:~:text=The%20AMOP%20structural%20domain%20is,C')
86. AnnotationURLCitation(end_index=35252, start_index=35085, title='Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24464222/#:~:text=affinity%20receptor%20for%20ISM%2C%20the,essential%20for%20its%20proapoptotic%20activity')
87. AnnotationURLCitation(end_index=35928, start_index=35774, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=Xenopus%20gastrula%20embryos,and%20physiological%20functions%20of%20isthmin')
88. AnnotationURLCitation(end_index=36270, start_index=36100, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=Distinct%20spatiotemporal%20expression%20of%20isthmin,1%20remains%20largely%20unknown.%20In')
89. AnnotationURLCitation(end_index=36705, start_index=36538, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=development%20of%20cancer%20by%20regulating,and%20treatment%20strategies%20for%20various')
90. AnnotationURLCitation(end_index=37399, start_index=37234, title='Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8429235/#:~:text=lipogenic%20to%20a%20protein%20synthesis,diabetes%20and%20fatty%20liver%20disease')
91. AnnotationURLCitation(end_index=37614, start_index=37400, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=have%20evaluated%20the%20therapeutic%20potential,goal%20for%20the%20near%20future')
92. AnnotationURLCitation(end_index=38219, start_index=38042, title='Isthmin: A multifunctional secretion protein - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37979212/#:~:text=like%20adipokine%2C%20increases%20adipocyte%20glucose,and%20treatment%20strategies%20for%20various')
93. AnnotationURLCitation(end_index=38427, start_index=38220, title='Frontiers | A brief overview about the adipokine: Isthmin-1', type='url_citation', url='https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.939757/full#:~:text=that%20ISM1%20may%20be%20a,potential%20therapeutic%20target%20for%20cancer')